Back to search
FDAFDA · Food and drugs·Recall number D-0674-2023

Cardioplegia Solution, Modified St Thomas Formula, low potassium, 70 mEq K, packaged in 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0210-1.

Published May 31, 2023 · Recall initiated: April 28, 2023

Summary

FDA records drug Class II recall D-0674-2023, published May 31, 2023 and initiated April 28, 2023. Recalling firm: Central Admixture Pharmacy Services, Inc.; Status: Terminated; Reported quantity: 208 bags; Lot: Lot # 37-894320, Exp 04/29/2023; 37-894324, Exp 04/29/2023; 37-897297, Exp 05/12/2023; 37-898509, Exp 05/15/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Central Admixture Pharmacy Services, Inc.
Distributor
Nationwide in the USA.
Lot
Lot # 37-894320, Exp 04/29/2023; 37-894324, Exp 04/29/2023; 37-897297, Exp 05/12/2023; 37-898509, Exp 05/15/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cardioplegia Solution, Modified St Thomas Formula, low potassium, 70 mEq K, packaged in 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0210-1. recalled?

Yes. FDA published recall D-0674-2023 on May 31, 2023. Reported hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail